Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | POLB | P06746 | 2/20 | 0.49 |
| ▸ | MAOB | P27338 | 3/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 5/20 | 0.38 |
| ▸ | TYR | P14679 | 2/20 | 0.38 |
| ▸ | LMNA | P02545 | 1/20 | 0.38 |
| ▸ | MAOA | P21397 | 1/20 | 0.36 |
| ▸ | SRC | P12931 | 2/20 | 0.35 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.33 |
| ▸ | RAB9A | P51151 | 1/20 | 0.33 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL6993015 | 0.98 | POLB (0.47) | POLBMAOBKDM4ETYRLMNA | |
| SCHEMBL13555550 | 0.81 | POLB (0.45) | POLBKDM4ETYRLMNASRC | |
| SCHEMBL17128901 | 0.81 | MAOB (0.41) | POLBMAOBKDM4ETYRLMNA | |
| Hydrochloric Acid SCHEMBL6992862 | 0.80 | POLB (0.47) | POLBMAOBKDM4ETYRLMNA | |
| SCHEMBL990461 | 0.80 | CYP1A2 (0.40) | POLBMAOBTYRLMNAMAOA | |
| SCHEMBL7554482 | 0.78 | MMP1 (0.40) | POLBMAOBKDM4ETYRMAOA | |
| SCHEMBL18680403 | 0.77 | KDM4E (0.42) | POLBKDM4EL3MBTL1ALDH1A1TDP1 | |
| Hydrochloric Acid SCHEMBL6989988 | 0.76 | MMP1 (0.39) | POLBMAOBKDM4ETYRMAOA | |
| SCHEMBL8102798 | 0.72 | POLB (0.44) | POLBKDM4ETYRLMNASRC | |
| SCHEMBL11926101 | 0.70 | TYR (0.40) | POLBMAOBKDM4ETYR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20020068758-A1 | Novel orally active iron (III) chelators | BTG INTERNATIONAL LIMITED. | 2002-06-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020068758-A1 | Novel orally active iron (III) chelators | HAMP, HRH2, GRHPR | POLB 4546/4885MAOB 2587/4885KDM4E 1012/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.